Rocket Lab: A Long-Term Owner's Perspective

【Fact】 On cost structure, Rocket Lab is explicit in its 10-K: costs include direct materials, labor, manufacturing overhead, shipping, depreciation and amortization, and personnel costs directly tied to delivery. More importantly, the company also runs at very high R&D intensity. Net R&D in 2025 was $209.6 million, and net R&D in Q1 2026 reached $80.5 million.

【Fact】 On dependence, the company is not fully diversified. In 2025, the top five customers contributed about 49% of revenue, and the top five backlog customers about 77% of backlog; the company also repeatedly flags that its business is affected by government policy, the defense budget, the supply chain, critical materials, and key personnel (especially Peter Beck).

【Opinion】 Is this a business I can understand? Yes — but only enough for a high-but-not-perfect score. The product, customer, and revenue logic are understandable; but the economics of any single project, Neutron's probability of success, the pace at which M&A synergies materialize, and the ultimate path to positive free cash flow are not yet simple enough for me to assess as calmly as I would Coca-Cola, Moody's, or a high-quality insurer. So my business-comprehensibility score is 3/5. If the stock market closed for five years, I would be willing to hold this company as an "excellent, growing industrial business" and keep watching; but at the current share price, I would not casually hold this stock for five years without checking the screen.

Industry and Competitive Landscape

【Fact】 By industry stage, Rocket Lab's market is clearly still growing. In Q1 2026, the company disclosed signing 31 new Electron/HASTE contracts in a single quarter, plus 5 new dedicated Neutron launch contracts, and noted that the number of launch contracts sold in Q1 2026 already exceeded the number of launches sold in all of 2025; the overall mission manifest exceeds 70 signed missions. At the same time, the company continues to expand across national security, missile defense, hypersonic testing, satellite propulsion, laser communications, robotics, and other directions.

【Fact】 Rocket Lab's track record is not theoretical. The company discloses that since Electron's first flight in 2017, it had completed 54 successful missions by the end of 2024 and delivered more than 200 spacecraft for government and commercial customers; in 2024, Electron was the second-most-frequently-launched orbital rocket operated by a U.S. company. In 2025, it completed another 21 launch missions, up from 16 in 2024.

【Inference】 But this remains a fast-growing, high-barrier industry whose returns are not naturally generous. The space industry inherently carries four attributes a value investor should watch: rapid technological iteration, heavy regulation, high capital intensity, and a competitive landscape easily reshaped by a single dominant player. Especially in launch, market pricing and customer expectations will almost certainly be anchored over the long run by larger, lower-cost, higher-capacity platform players. Rocket Lab's response is to transform itself from a single-point launch provider into a more integrated space platform. The direction is right, but it does not guarantee that the endgame economics will be excellent.

【Opinion】 Viewed through an economic lens, the most important competitors are not "small-rocket peers" but strong platform players capable of reshaping a customer's total cost curve for launch and missions; and at the spacecraft, component, and defense-mission level, it must also contend with more traditional large aerospace-and-defense suppliers and specialist component makers. So Rocket Lab sits in a classic position: a great racetrack that does not hand you excess profit for free. My characterization of the industry is a "difficult business inside a growth industry," or more precisely, "a great racetrack, but not a naturally good-business racetrack." Accordingly, my industry-attractiveness score is 3/5.

Moat and Management

Moat Assessment

【Fact】 Rocket Lab's real moat starts not with brand advertising but with its execution record, engineering heritage, regulatory qualifications, and infrastructure assets. The company owns a private orbital launch site; Electron had 54 successful missions by the end of 2024; in 2025, Launch Services revenue reached $199 million with segment gross profit of $81.3 million, showing it is not a "lab that flies once" but a company that has crossed from technology demonstration into repeatable commercial fulfillment.

【Inference】 The difficulty of replicating this kind of moat lies not in "whether you can build a rocket" but in "whether you can build a sustained delivery system for launch and missions." To replicate Rocket Lab's current base would most likely require many years of time, billions of dollars of capital, sustained supply-chain integration, the build-out of a compliance system, success across multiple key programs, and enough flight validation on top of all that. So I believe it has a real moat — but to date that moat shows up more as a barrier to entry than as excess return on capital. In value investing, those two are not the same concept.

【Opinion】 My conclusion on the state of its moat is: "stable, slightly widening, but not yet wide enough for valuation to ignore cash-flow reality." The widening comes from Space Systems' capability expansion, acquisitions filling out the component chain, and strengthening stickiness among defense customers; the narrowing risk comes from Neutron not yet being commercialized, persistent long-term competitive pressure, and the company's need to keep proving that new businesses are not "revenue stacking, margin diluting." Moat-strength score: 3/5.

【Inference】 The company's ability to raise prices in an inflationary environment is partially, not broadly, present. In highly customized satellite components, defense missions, and programs with long qualification cycles, there is more room to raise prices than in standardized launch; but in the launch market, customers will always compare prices against the alternatives offered by larger platforms, so pricing power is constrained. In a downturn, defense and government demand is steadier than commercial constellations, but Rocket Lab does not currently support its valuation on being able to "stay profitable even in a downturn" — it relies on its cash reserves and ability to raise capital in the markets. So the past improvement in gross margin looks more like scale and business-mix improvement than a proven structural high-margin windfall.

Management and Capital Allocation

【Fact】 On management, Peter Beck remains the company's single most important person. In its 2026 proxy filing, the company disclosed that Peter Beck holds beneficial ownership of roughly 46.44 million shares, corresponding to about 7.5% of voting power; that figure includes 45.95 million shares of Series A Preferred Stock held by his family trust, which can convert into common stock on a 1:1 basis. All directors and officers together hold about 8.4% of voting power.

【Fact】 This holding is not merely "having shares" — it comes with governance arrangements. The proxy filing discloses that from late 2024 into early 2025, the company conducted a share exchange with the Beck family trust, swapping 50.95 million common shares for 50.95 million shares of Series A Preferred Stock. Beyond carrying the same per-share voting rights, that preferred stock grants the holder the right to designate at least one director and retains special voting rights over certain charter amendments affecting preferred-stock rights. The arrangement triggers automatic conversion under circumstances such as Beck no longer serving as CEO, death/permanent disability, or his holding falling below 5%.

【Opinion】 This governance structure clearly cuts both ways. On the positive side, it reinforces founder control and a long-term orientation, shielding a long-cycle industry like space from short-term market noise; on the negative side, it reduces the governance symmetry between minority shareholders and the founder. For a value investor, this is not a fatal problem, but it must be faced squarely. If you demand "one share, one vote" governance purity, this is not a point in its favor.

【Fact】 On the other hand, in March 2026, Beck voluntarily cut his annual salary to $1 or the New Zealand statutory minimum wage, and forfeited his year-end bonus and a portion of unvested RSUs; company filings also disclose he canceled 392,155 unvested RSUs. This move strongly signals "I want to place the center of gravity of my incentives on long-term shareholder value, not on near-term cash and equity awards."

【Opinion】 I view this positively, but I will not over-romanticize it. A founder's pay cut is a posture, not a cash flow. What really matters is whether he can take capital allocation from "makes sense" to "effective on a per-share basis." Over recent years Rocket Lab has done M&A with one hand and equity raises with the other: in 2025 the company raised gross proceeds of about $1.146 billion through two ATM offerings, and in Q1 2026 it raised gross proceeds of about $450 million through an ATM. This greatly strengthens the balance sheet, but it also makes one thing clear: the company's reliance on the capital markets remains very strong, and shareholders are being continuously diluted.

【Fact】 By share count, common shares were roughly 450 million at the end of 2021; about 454 million at the end of February 2025; about 567 million on February 20, 2026; and by March 31, 2026, common shares outstanding were about 576 million, with common-equivalent issued shares reaching 622 million when preferred is converted on a 1:1 basis. The basic weighted-average share count in the Q2 2026 guidance has also reached 629 million, including about 46 million preferred shares.

【Opinion】 So my assessment of management and capital allocation is this: I largely trust the people, and the direction is broadly reasonable, but "per-share value growth" has not yet been proven. M&A-driven expansion, platform build-out, and conservative financing all have their rationale; the problem is that the ultimate test of capital allocation is not revenue and narrative, but per-share intrinsic value. On that, Rocket Lab is still "awaiting the exam," not "graduating with honors." Management and capital-allocation score: 4/5 for the people, 3/5 for the results, a blended 3.5/5.

Financial Quality

Key Financial Table

The table below uses verifiable data disclosed by the company wherever possible; amounts are in millions of dollars unless otherwise noted. Because this round of my research did not fully pull out a standalone 2022 CapEx breakdown, individual items are marked "not fully verified." Sources are the company's 2025 10-K, 2024 10-K, the 2021/2020 audited statements attached to the 2022 Q1 10-Q, and the 2026 Q1 10-Q / quarterly announcement.

• 2020 is on a retrospectively adjusted basis. ** Values disclosed for February 21, 2025 and February 20, 2026 / March 31, 2026, respectively.

【Fact】 One very important positive change is that revenue and gross margin are indeed improving clearly. 2020 revenue was only $35.16 million, growing to $602 million by 2025; gross margin improved from -33.6% to 34.4%, reaching 38.2% in Q1 2026. By segment, 2025 Launch Services revenue was $199 million with $81.3 million of gross profit, and Space Systems revenue was $403 million with $125.9 million of gross profit. This shows the company is not merely "diluting losses by doing more projects" — it has genuinely improved at the gross-profit level.

【Fact】 But the more important negative reality is that operating cash flow has never turned positive, and free cash flow is worse. From 2020 to 2025, operating cash flow was -$27.76 million, -$71.79 million, -$106.5 million, -$98.87 million, -$48.89 million, and -$165.5 million, respectively; 2025 CapEx rose further to $156.3 million. Q1 2026 operating cash flow was still -$50.33 million, with CapEx of about $27.07 million. This means that, to this day, Rocket Lab remains a company that needs external capital to fund its growth, not one that can self-fund its growth from internal cash.

【Fact】 Working capital is likewise consuming cash. Inventory rose to $158.4 million in 2025 and further to $183.1 million in Q1 2026; contract liabilities decreased by $21.61 million in 2025 and increased again by $45.75 million in Q1 2026; in Q1 2026, accounts receivable rose from $39.00 million at the end of 2025 to $74.96 million, and contract assets rose from $61.61 million to $75.04 million. This is the classic profile of a project-based hard-tech growth company: the faster revenue grows, the more readily working capital eats cash first.

【Fact】 The balance sheet itself is actually not bad. As of March 31, 2026, the company had $1.205 billion in cash, $271 million in marketable securities, total assets of $2.820 billion, total liabilities of $556 million, and book shareholders' equity of $2.264 billion. In other words, the company is not currently being crushed by debt; its viability comes mainly from the net-cash buffer formed after equity financing.

【Opinion】 This financial picture leads me to a clear conclusion: First, the phrase "earnings quality" should not currently be applied to Rocket Lab, because it does not yet have "earnings" — only steadily improving gross profit and a total-cost structure that has not yet converged. Second, accounting profit has not been obviously dressed up; on the contrary, the losses and cash burn are real losses. That actually lowers my suspicion of "good financials, bad cash." Third, the biggest financial risk is not high leverage but persistent capital consumption at a high valuation. If the company runs into large development outlays, a rough M&A integration, or a Neutron delay in the future, it may not die, but shareholders could keep getting diluted.

【Fact】 From an accounting and internal-control standpoint, I did not see in this round of materials any clear evidence of financial fraud, major restatement, or profit manipulation; management and the auditors each disclosed effective internal controls for 2024 and 2025. What needs ongoing attention is not "whether there are fake profits" but revenue-recognition policy, the goodwill and intangibles created by acquisitions, contingent consideration, fair-value items, and the erosion of per-share value by heavy equity compensation.

Owner Earnings and Intrinsic Value

A Conservative Owner Earnings Estimate

【Fact】 Using 2025 as the baseline, Rocket Lab's GAAP net loss was about $198.2 million; depreciation and amortization about $43.94 million; stock-based compensation about $71.10 million; operating cash flow -$165.5 million; and CapEx $156.3 million. The 2025 cash-flow statement also shows that the change in working capital consumed about $58.80 million of cash on net for the year.

【Opinion】 Under a conservative Buffett-style Owner Earnings approach, I would handle it this way:

• Net income: start from the GAAP net loss.

• Add back non-cash expenses: I can add back depreciation and amortization; but I will not fully add back stock-based compensation, because although it does not immediately flow out as cash, it is a real cost to shareholders.

• Deduct maintenance CapEx: this is the hardest part of the case. 2025 total CapEx of $156.3 million is clearly mixed with substantial Neutron and capacity build-out and cannot all be treated as maintenance; yet space manufacturing cannot plausibly treat maintenance CapEx as very low either.

• Working capital: it is clearly still consuming cash and cannot be waved away as short-term noise.

Based on these considerations, I offer a conservative estimate range for 2025 Owner Earnings:

【Opinion】 The conclusion is very direct: Rocket Lab's "true distributable cash flow" is still negative today. Even if you draw a very generous line on CapEx and treat only part of it as maintenance, its Owner Earnings still does not turn positive. So the question "how many times Owner Earnings does the current valuation imply" has no normal answer today — because the denominator is still negative. For a value investor, this is the single most important point: what you buy today is not the existing owner earnings, but the owner earnings that might appear ten years from now.

Three Valuation Methods

Two things up front. First, the valuations below are 【Assumptions】, not facts and not management guidance. Second, Rocket Lab is the classic "heavy investment up front, high leverage later" company, and its valuation is extremely sensitive to assumptions, so I place more weight on "ranges" and "the required margin of safety" than on a point estimate precise to the single digit.

Discounted Owner Earnings

I use 2025 revenue of $601.8 million, Q1 2026 revenue of $200.3 million, and Q2 2026 guidance revenue of $225 million to $240 million as short-term anchors; I roughly treat 2026 revenue as a starting point near the $900 million level, then run three scenarios. The current price is still based on roughly $124.77.

If I roughly use the Q1 2026 common-plus-convertible-preferred-equivalent share count of about 622 million shares, the corresponding per-share values are approximately:

【Opinion】 Even in the relatively optimistic case, I find it very hard to read the current price of about $125 as "cheap." To defend today's price, you would need to believe, simultaneously, that:

• Neutron largely succeeds on plan;

• Space Systems keeps growing fast with continually expanding margins;

• M&A integration keeps succeeding;

• dilution slows meaningfully;

• and ten years out, Rocket Lab's owner earnings reach several billion dollars. That is not impossible, but it clearly already lies beyond the bounds of "conservative, verifiable, with a margin of safety."

Relative Valuation

【Fact】 Traditional P/E, EV/EBITDA, and P/FCF currently largely break down for Rocket Lab, because the company is still posting net losses, negative operating cash flow, and negative free cash flow. What can be computed directly are instead sales multiples and book-value multiples. Based on the current common-stock market cap of about $72.2 billion and 2025 revenue of $601.8 million, P/S is about 120x; on the Q1 2026 balance sheet, with book shareholders' equity of $2.264 billion, P/B is about 31.9x. On the economically more conservative "common-plus-convertible-preferred-equivalent" basis, equity value sits closer to $78 billion, pushing the multiples higher still.

【Opinion】 What does this tell us? It tells us that Rocket Lab's pricing today is not "priced on current profit, cash flow, or assets" but priced on a very distant dominant position. For a company still in a heavy capital-investment phase that has not yet proven long-term ROIC, the margin for error in such a valuation is extremely low. Even without any peer comparison, looking at it on its own is enough to conclude: the current valuation is very expensive.

Asset Value and Liquidation Value

【Fact】 As of March 31, 2026, the company's book shareholders' equity was $2.264 billion; goodwill $208.7 million, intangibles $220.6 million. Crudely stripping out goodwill and intangibles, tangible book equity is about $1.835 billion. On a common-plus-preferred-convertible-equivalent share count of about 622 million shares, tangible book value is only about $2.95 per share; even using total book net assets, it is only about $3.64 per share.

【Opinion】 This shows that Rocket Lab's market price comes almost entirely from future option value, not from asset value recoverable today. For a stock at about $125, this is not a small gap but a gap between "two different worlds." What the asset method yields here is not a reason to buy but a reminder: if future expectations are revised down significantly, the assets cannot provide meaningful downside protection.

Margin of Safety Assessment

Based on the three methods above, I offer the following price bands:

【Opinion】 So my answer to "is the current price cheap enough" is: no, and clearly not. The most fragile assumption in the valuation is not "whether revenue will grow" but whether, ten years out, the company can actually become a high-Owner-Earnings, low-dilution, strong-ROIC platform-style space enterprise. As long as that path is even a bit slower, the margins a bit lower, or the valuation multiple compresses a bit, the current share price will struggle to deliver the long-term return a balanced investor requires. In other words, it is quite possibly "a good company at a bad price."

Risks, the Bear Case, and Opportunity Cost

Main Risks

Competitive risk. Rocket Lab operates in a highly competitive industry, and prices and customer expectations will be influenced by larger platform players. In its 10-K, Rocket Lab itself repeatedly flags that it operates in "competitive and highly regulated industries," and stresses that launch cadence, Neutron development, customer demand, the supply chain, and government policy could all affect results.

Technological-substitution and technical-execution risk. For the current valuation, Neutron is not optional but almost a must-succeed growth engine. As of Q1 2026 the company still describes Neutron's first flight as a "later this year" target, but for projects like this, any timing slip, cost overrun, or first-flight failure damages the valuation logic directly.

Regulatory and government-budget risk. The company is increasingly embedded in government, national-security, and hypersonic-test missions, which brings stable demand but also the risks of budget approval, policy turnover, and shifting program cadence. The company also explicitly flags that a government-operations interruption and funding interruption could affect revenue, profit, and cash flow.

Customer-concentration risk. In 2025, the top five customers accounted for about 49% of revenue, and the top five backlog customers for about 77% of backlog. A delay, budget adjustment, or termination of one or two large customers' projects is enough to distort multiple quarters.

Supply-chain risk. Among its risk factors, the company directly cites the risk of access restrictions on key raw materials, components, and rare-earth materials. For a high-reliability hard-tech company, this kind of risk is usually not a mild margin wobble but a potential direct hit to delivery capability and the cadence of cash collection.

Financial and dilution risk. Rocket Lab's balance sheet is very safe in the short term, but the source of that safety is mainly cash from frequent share issuance, not internally generated cash flow. The ATM financings in 2025 and Q1 2026 are a powerful defense, but for existing shareholders they also mean "the company is very rational at a high valuation, and shareholders are easily diluted at a high valuation."

M&A-integration and capital-allocation risk. The company has clearly walked a platform-expansion path in recent years; the 2025 cash-flow statement shows net cash used for business acquisitions of $132.4 million that year, and Q1 2026 continued to see M&A cash outflows. The strategic direction of the M&A is not necessarily wrong, but the more acquisition-driven it is, the more one must watch whether revenue expansion is outpacing per-share value creation.

Governance risk. Founder control reinforces long-termism, but the Series A Preferred arrangement also brings a special director-nomination right and additional protective provisions. This is not financial leverage, but it is governance leverage. Should the priorities of the founder and common shareholders diverge in the future, common shareholders are not in the most symmetric position.

The Strongest Bear Case

【Strongest Bear Argument】 Rocket Lab may indeed be one of the finest publicly listed companies in the space sector, but the finest company in a sector can also be one of the worst investments — if the price you pay already implies too much future success. Buying Rocket Lab today is not buying the reality of 2025's $600 million in revenue, negative free cash flow, and high CapEx; you are buying a future version that "can become a core space-infrastructure platform and generate enormous distributable cash flow." And for that future version, the price the market is paying now is already very close to "passing acceptance in advance."

From the bear's vantage point, they may see three things. First, even if Neutron succeeds technically, it may not succeed economically; second, growth is driven mainly by heavy investment, M&A, and share issuance, not by per-share cash compounding; third, multiple compression alone is enough to cause long-term capital loss, even if the company keeps growing. Because when a stock's main value comes from imagined upside ten years out, any execution slowdown is not a "small correction" but a "re-rating."

Comparison With Other Opportunities

【Opinion】 Compared with the strongest competitors in the industry, Rocket Lab may be the purer, more accessible, more growth-elastic listed name; but it clearly is not the safer one. Compared with a broad index, Rocket Lab's return distribution is noticeably more dispersed, its downside protection noticeably weaker, and it currently has no verifiable cash-flow anchor. Compared with risk-free yields or high-grade bonds, it pays no interest and no dividend, and its investment return rests almost entirely on far-off cash flows materializing plus the market continuing to be willing to award a high multiple.

【Opinion】 So, for a balanced, 10-year-plus, value-leaning investor, my judgment is:

• Buying it now is not clearly better than buying the index.

• Its potential return may be high, but at the current price, the expected return may not be enough to compensate for execution risk and multiple-compression risk.

• If your portfolio can hold only 5 assets, at the current price, I would not include it.

• But if your goal is to track, over the long term, a company that might evolve from an "excellent growth company" into a "truly high-quality space platform," it absolutely deserves a place on the priority watch list.

Open Questions and Limitations

There are three points I need to state clearly here. First, this round I mainly verified full-year data for 2020–2025 plus 2026Q1, and did not fully reconcile the earlier 2019 data. Second, directly comparable public peers are few, and most have similarly unstable profitability, so the traditional peer-multiple method is inherently not robust in this sector. Third, the changes in the 2025 convertible-bond carrying amount and the Q1 2026 carrying amount — I did not fully unpack all the accounting detail this round, so on the rigorous EV basis I give an approximate range rather than a precise value.

These limitations do not change the direction of my conclusion: the core problem with the current price is not "being a few hundred million off on the EV basis," but "the share price running significantly ahead of verifiable cash flow."

Checklist and Final Conclusion

Investment Checklist

Final Investment Conclusion

【Final Rating】 Watch

【One-Sentence Investment Thesis】 Rocket Lab is quite possibly a genuinely capable space-platform company, but at the current price it looks more like a growth stock with "far-off success already heavily priced in" than a value stock with a margin of safety.

【Core Bull Case】

• The business has upgraded from a single small rocket to a platform-style space company, with Space Systems now the larger source of revenue.

• Execution capability is real: Electron had 54 successful missions by the end of 2024, and launch missions rose to 21 in 2025.

• Gross margin has improved markedly: -33.6% in 2020, 34.4% in 2025, and further to 38.2% in Q1 2026.

• Backlog and liquidity are both strong: backlog of $1.847 billion at the end of 2025, surpassing $2.2 billion in Q1 2026; ample cash and securities on hand.

• The founder remains deeply aligned, further signaling a long-term orientation through a pay cut and RSU cancellations.

【Core Bear Case】

• Owner Earnings and free cash flow are still negative, with no proof to date that it can become a "cash machine."

• The current valuation is extremely expensive: about $72.2 billion market cap on a common-stock basis, corresponding to about 120x price-to-sales for 2025.

• Neutron's success is an important precondition for the high valuation to hold, yet its technology, timeline, and economics remain unverified.

• Ongoing dilution is a real cost: the ATM financings in 2025 and Q1 2026 greatly strengthen cash, but also dilute shareholders.

• The governance structure is more founder-friendly than symmetrically friendly, requiring common shareholders to accept stronger founder control.

【Key Assumptions】

• Neutron makes a successful first flight within the next few years and achieves acceptable unit economics.

• Space Systems keeps growing fast and gradually converts its segment gross-margin advantage into operating profit and cash flow.

• The capability expansion from M&A ultimately shows up in per-share intrinsic value, not merely revenue scale.

• The pace of dilution slows markedly, and future CapEx and working-capital consumption are gradually covered by internal cash flow.

• After the company matures, the market remains willing to award it a valuation premium above an ordinary industrial company.

【Fair Buy Price】 $25 to $40 per share. The basis is my estimate of a conservative-to-neutral intrinsic-value range of $24 to $56 per share, with a requirement of a roughly 30% margin of safety on top. The current level of about $125 is clearly outside this range.

【Target Holding Period】 Only after buying at a significantly lower price, and after confirming a clearer path for Neutron and cash flow, would it be suitable for a holding period of 10 years or more. At the current level, it is better suited to "long-term tracking" than to "long-term heavy positioning."

【Expected Annualized Return】 The following is a subjective range starting from the current price — not a price forecast, but my intuition for the return when "valuation already reflects success in advance":

• Conservative scenario: -12% to -8% per year

• Neutral scenario: -6% to -1% per year

• Optimistic scenario: 0% to +5% per year

The reason even the optimistic scenario is not high is not that I am bearish on the company's growth, but that the current buy price is already very high. As long as the multiple regresses even slightly, the long-term return will be largely swallowed.

【Maximum Loss Risk】 The core scenario for permanent capital loss is not bankruptcy, but "the company keeps growing, yet far short of the current valuation's expectations." If Neutron is delayed, free cash flow takes a long time to turn positive, or the company keeps issuing shares at high prices or the sector's valuation cools, the stock could well see a long-term drawdown of 50% to 80%, even as the fundamentals still "look fine." This kind of loss most easily misleads investors, because it is not a bad company but a good company bought too dear.

【Tracking Metrics】 Going forward, I will focus on these metrics:

• Neutron's first-flight timing, test results, and subsequent reuse and capacity cadence

• Launch Services segment gross margin and mission cadence

• Space Systems segment gross margin and the quality of order conversion

• Whether operating cash flow keeps improving without relying on share issuance

• Whether CapEx shifts from "rapid expansion" to "coverable by internal cash"

• Backlog growth and the pace at which backlog converts into revenue

• Whether the top-five-customer share keeps rising

• Stock-based compensation and the growth rate of total share count

• Post-acquisition goodwill, intangibles, integration costs, and impairment risk

• Whether management keeps communicating capital allocation in terms of "per-share value" rather than "total scale"

【Signals That Trigger a Reassessment】

• A major Neutron delay, or poor unit economics revealed after the first flight

• Gross margin falling back to the low-to-mid 20s with no improvement in cash flow

• Another large equity raise without a commensurate return outlook

• A large downward revision in backlog or rising cancellations

• Loss of core customers/government programs

• A large acquisition bringing high goodwill but synergies falling short

• Founder-control arrangements strengthening further to the point of harming common-shareholder symmetry

• Clear deterioration signals in accounting policy, revenue recognition, contingent consideration, or goodwill impairment

【Final Recommendation】 Rocket Lab is worth researching for the long term; it is not worth talking yourself into buying at the current price in the language of "value investing." If you are a growth investor, you can grant that it might be a long-term big winner, but you must also grant that the odds today are not generous. If you are a long-term value investor, the most disciplined and rational approach is not to rush to conclude "never buy," but to place it on a high-priority watch list and wait for at least one of the following to happen: either the price comes down, or the cash flow comes up. Until at least one of those happens, my recommendation is: keep watching, do not chase the price, and do not mistake an "excellent company" for a "cheap stock."

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.